(Q46723716)

24 December 2017

title

Primary chemotherapy with low-dose prolonged infusion gemcitabine and cisplatin in patients with bladder cancer: a Phase II trial (English)

1 reference

24 December 2017

main subject

phase II clinical trial

0 references

1 reference

Hussein Khaled

1

1 reference

24 December 2017

Mohamed E Emara

2

1 reference

24 December 2017

Rabab M Gaafar

3

1 reference

24 December 2017

Osman Mansour

4

1 reference

24 December 2017

Ahmed Abdel Warith

5

1 reference

24 December 2017

Mohamed S Zaghloul

6

1 reference

24 December 2017

Osama El Malt

7

1 reference

24 December 2017

publication date

14 January 2008

1 reference

24 December 2017

published in

Urologic Oncology

1 reference

24 December 2017

volume

26

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

133-136

1 reference

24 December 2017

A phase I clinical, plasma, and cellular pharmacology study of gemcitabine

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Antitumor activity of prolonged as compared with bolus administration of 2',2'-difluorodeoxycytidine in vivo against murine colon tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Prolonged infusion gemcitabine: a clinical phase I study at low- (300 mg/m2) and high-dose (875 mg/m2) levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Phase II trial of gemcitabine as prolonged infusion in metastatic breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Phase I trial of weekly gemcitabine at 3-h infusion in refractory, heavily pretreated advanced solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Prolonged infusion of gemcitabine in advanced solid tumors: a phase-I-study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Systemic chemotherapy for patients with bladder cancer--current controversies and future directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Long-term survival in metastatic transitional-cell carcinoma and prognostic factors predicting outcome of therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

A phase II study of gemcitabine plus cisplatin chemotherapy in advanced bilharzial bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Gemcitabine plus cisplatin, an active regimen in advanced urothelial cancer: a phase II trial of the National Cancer Institute of Canada Clinical Trials Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Phase II trial of gemcitabine plus cisplatin in patients with metastatic urothelial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Primary chemotherapy with gemcitabine as prolonged infusion, non-pegylated liposomal doxorubicin and docetaxel in patients with early breast cancer: final results of a phase II trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2007.01.013

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.UROLONC.2007.01.013

1 reference

24 December 2017

1 reference

24 December 2017